Zalunfiban (INN; code name RUC-4, proposed trade name Disaggpro) is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitors class. It is intended for the emergency prehospital treatment of ST elevation myocardial infarction (STEMI), a type of heart attack with specific ECG findings.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.